Therefore, it is highly possible that viral dsRNA activates NLRP1 by binding to it through a leucine-rich repeat domain of NLRP1 and participates together with NLRP3 to the over-responses of the immune system leading to COVID-19 severe symptoms (Bauernfried et al., 2021). This evidence concerns the gene NLRP3 and COVID-19.